VeriSim Life Partners with Clarivate

Written By Alyssa Kolb

VeriSIM Life, the leading artificial intelligence (AI)-enabled, unique R&D decisions de-risker for breakthrough drug development, this week announced a partnership with Clarivate, a global leader in connecting people and organizations to intelligence they can trust.

The partnership will improve pre-clinical success rates by leveraging VeriSim’s AI drug decision engine and R&D drug discovery intelligence platform from Clarivate. VeriSim is a Serra Capital III and Serra III SBIC company.

To view the full article, follow here.

Alyssa Kolb
Previous

Cardea Bio Acquired by Paragraf
Next

Myagi Acquired by Rallyware